HPV vaccine 580299 (Cervarix)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HPV vaccine 580299 (Cervarix), covering 2010-03-05 to 2010-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age [Phase 3]